Related Experiment Video
Updated: Jun 10, 2026
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
[New perspectives in prostate cancer management]
L Boccon-Gibod1, J-L Davin, C Coulange
1Clinique urologie, hôpital Bichat-Claude-Bernard, université Paris VII Denis-Diderot, 46, rue Henri-Huchard, 75877 Paris cedex 18, France.
Abstract:
The treatment of prostate cancer is experiencing important innovations. Hormone therapy includes a new class of drugs: LHRH antagonists, which induce a rapid, fast and sustained reduction of testosterone levels. Active surveillance enables to avoid an aggressive treatment without decreasing survival, provided that strict eligibility and follow-up criteria are applied. New imaging techniques and laboratory assays lead to early diagnosis of small size tumors. Lastly, focal therapy has the potential to target localized cancers without deterioration of surrounding structures. These concomitant improvements offer the clinician and the patient attractive options for prostate cancer management. However, they are not devoid of limitations and constraints. Thus, it is crucial to define the most appropriate patient's profile for each therapeutic option, taking into account the objective characteristics of the tumor and the psychological features of the patient.
Insights
Innovative prostate cancer treatments offer new options like LHRH antagonists for hormone therapy and active surveillance. Early diagnosis and focal therapy also improve management, but careful patient selection is crucial for optimal outcomes.
Area of Science:
- Oncology
- Urology
- Endocrinology
Context:
- Prostate cancer management is evolving with significant therapeutic advancements.
- Traditional treatments are being complemented by novel approaches.
- The need for personalized treatment strategies is increasing.
Purpose:
- To review recent innovations in prostate cancer treatment.
- To highlight new therapeutic options and diagnostic tools.
- To emphasize the importance of patient-specific treatment selection.
Summary:
- New hormone therapies, including LHRH antagonists, provide rapid testosterone reduction.
- Active surveillance offers a non-aggressive approach with strict criteria.
- Advanced imaging and lab tests facilitate early detection of small tumors.
- Focal therapy enables targeted treatment of localized prostate cancer.
- These advancements present new management choices for clinicians and patients.
Impact:
- Improved patient outcomes through tailored treatment strategies.
- Potential for reduced morbidity associated with aggressive treatments.
- Enhanced early detection rates for prostate cancer.
- Personalized medicine approaches are becoming central to prostate cancer care.
More Related Videos
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
